Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology

Figure 2

(a) The body weight. (b) Effect of berberine on CMDI. (c) Pathological changes of colon (compared with normal control group,  < 0.05 and  < 0.01; compared with model group,  < 0.0 and  < 0.01; H&E staining, x100; A, normal group; B, model group; and C, berberine group).

(a)

(b)

(c)